We serve Chemical Name:2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide CAS:82199-12-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide](https://a.dearchem.com/CAS2/82199-12-0.png)
Chemical Name:2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
CAS.NO:82199-12-0
Synonyms:2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
Molecular Formula:C18H17N5O4
Molecular Weight:367.35900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:495.8ºC at 760 mmHg
Density:1.43 g/cm3
Index of Refraction:1.676
PSA:128.77000
Exact Mass:367.12800
LogP:2.61780
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide Use and application,2-[(2-methoxyphenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide technical grade,usp/ep/jp grade.
Related News: Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. 16,19-bis(trimethylsilyl)-15,16,17,18,19,20-hexadehydroyohimbane manufacturers The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. N-(2-hydroxybenzyl)-N-(2-((2-hydroxybenzyl)(2-oxo-2-propoxyethyl)amino)ethyl)glycine suppliers developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI 3,3,3-trichloro-2-ethylsulfanyl-propene vendor & factory.
